Our Science
Personal Profile
Every website has a story, and your visitors want to hear yours. This space is a great opportunity to give a full background on who you are and what your site has to offer. Double click on the text box to start editing your content and make sure to add all the relevant details you want site visitors to know.
If you’re a business, talk about how you started and share your professional journey. Explain your core values, your commitment to customers, and how you stand out from the crowd. Add a photo, gallery, or video for even more engagement.
Therapeutic mouthwashes reduce dental plaque by using antimicrobial compounds like chlorhexidine or ethanol. However, these harsh chemicals not only target harmful bacteria but also eliminate the beneficial ones, disrupting the natural oral microbiome. This is why the American Dental Association does NOT recommend traditional antimicrobial mouthwashes for children under six—they can be toxic if accidentally swallowed.
MayPall mouthwash, on the other hand, contains NO toxic antimicrobial chemicals. Instead, it relies on a unique anti-biofilm (or antiplaque) mechanism. The primary ingredients in MayPall prevent cavity-causing bacteria, Streptococcus mutans, from adhering to tooth surfaces and forming plaques. These key anti-biofilm ingredients, derived from maple and green tea, make MayPall a safe choice if swallowed, suitable for children of all ages—and for adults seeking a natural approach to oral care.
The anti-biofilm properties of maple sap were discovered by Dr. Elbakush (MayPall Co-Founder) and Dr. Gomelsky (MayPall Co-Founder and President) in the Department of Molecular Biology at the University of Wyoming. Their research is supported by pending patent applications and peer-reviewed publications.
• Gomelsky M, Elbakush AE, Fulano AE. Materials and methods for inhibiting, preventing, and dispersing biofilms. US Patent App. 63/533,292 (Priority date 2023-08-17).
• Gomelsky M, Elbakush AE. Methods and compositions for the prevention and treatment of dental caries. U.S. Patent App. 63/638,144 (Priority date 2024-04-24).
• Elbakush AM, Trunschke O, Shafeeq S, Römling U, Gomelsky M. 2024. Maple compounds prevent biofilm formation in Listeria monocytogenes via sortase inhibition. Front Microbiol (in review)
• Elbakush AM, Fulano AM, Gomelsky M. 2023. Lignan-containing maple products inhibit Listeria monocytogenes biofilms on fresh produce. Front Microbiol 14:1258394. https://doi.org/10.3389/fmicb.2023.1258394
